Digestive Disease Week 2021 (DDW 2021)
21 May - 23 May, 2021, United States
In obese patients without gallstones, a 6-month treatment course of ursodeoxycholic acid (UDCA) following bariatric surgery may reduce their likelihood of developing symptomatic gallstones, according to findings of the UPGRADE trial from The Netherlands presented at DDW 2021.
An analysis of patients with moderately to severely active ulcerative colitis (UC) highlighted the general safety of the oral sphingosine-1-phosphate (S1P) receptor 1 and 5 modulator ozanimod, according to a presentation at Digestive Disease Week 2021.
Use of prednisone prior to SARS-CoV-2 diagnosis may be linked to a higher risk of severe COVID-19 outcomes such as hospitalization, intensive care unit (ICU) admission, and death, according to a retrospective community-based study.
